Peripheral Neuropathy: Symptoms, Red Flags and What Helps

This page is written for the person living with it — what it feels like, what to do, and when to worry. For the clinical reference on the same condition — epidemiology, pathophysiology, staging and treatment — see Peripheral Neuropathy in Neurology.

Table of Contents

1. Overview: The Damage Behind the Symptom
2. What It Actually Feels Like
3. The Stocking-Glove Pattern
4. The Common Causes
5. Serious and Less Common Causes
6. Red Flags — Get Help Urgently
7. How It Is Evaluated
8. What Helps: Self-Care and Physical Measures
9. What to Expect Over Time
10. Connections
11. References & Research
12. Featured Videos

Overview: The Damage Behind the Symptom

Peripheral neuropathy means the nerves outside your brain and spinal cord — the long cables running to your hands, feet, skin, and internal organs — are injured or dying back. It is not one disease; more than a hundred conditions can start the process.

Here is the distinction worth keeping. Our Numbness and Tingling page is about the sensation — pins and needles, the arm that went dead because you slept on it, which has causes with nothing to do with nerve damage: a pinched nerve root, poor circulation, hyperventilation, low calcium. Peripheral neuropathy is what you have when the numbness comes from real injury to the fibres themselves — the wiring is degenerating, not temporarily squashed.

It is common and under-recognised: roughly 2–3% of adults, about 8% over age 55. Half of people with diabetes develop it, and many already have measurable damage on the day they are diagnosed. Three facts shape the rest of this page:

• Nerves die back from the far end first. That is why it starts in the toes and why it is symmetrical.
• Some causes are fully reversible and some are not. A B12 deficiency caught at six months is a different story from one caught at three years, which is why early recognition changes the outcome.
• Even an irreversible cause can be slowed and its symptoms treated. "Nothing can be done" is almost never true.

Back to Table of Contents

What It Actually Feels Like

The words people use tell a doctor which kind of nerve fibre is failing. Nerves are a bundle of different-sized fibres with different jobs, and they do not fail in lockstep.

Small-Fibre Symptoms (Pain and Temperature)

The thinnest fibres carry pain, heat, cold, and itch, and also run sweating and blood-vessel tone. When they go first, the experience is loud:

• Burning in the soles, worst at night — like standing on hot sand or walking on gravel.
• Allodynia — the bedsheet hurts; light touch is read as pain. Real, well documented, and often disbelieved by others.
• Lost temperature sense, so scalding bathwater goes unnoticed, plus dry, cracked, hairless skin, because the same fibres run the sweat glands.

Large-Fibre Symptoms (Touch, Vibration, Position)

The thick fibres carry vibration, light touch, and proprioception — your unconscious sense of where your limbs are. When these fail the experience is quiet, which is exactly why it is dangerous:

• Numbness like thick socks, a rubber glove, or felt between foot and floor.
• Balance trouble in the dark, because vision had been quietly compensating for the lost position sense.
• Not feeling an injury: a blister, a tack in the shoe, a pebble worn all day. This is the road to a diabetic foot ulcer.

Motor and Autonomic Symptoms

Later, motor fibres join in: toes that will not lift, tripping on carpet edges, unsteady wide-based walking, and thinning of the muscle between thumb and index finger. Autonomic fibres cause lightheadedness on standing, early fullness after small meals, diarrhoea alternating with constipation, and either absent sweating or drenching sweats in odd places.

Back to Table of Contents

The Stocking-Glove Pattern

The most useful clue in neuropathy is where it is. Most metabolic and toxic neuropathies produce a distal symmetric polyneuropathy, called the stocking-glove pattern because the affected area looks like an invisible sock, and later an invisible glove, drawn onto the body. Departures from it — asymmetry, a band of numbness around the trunk, hands before feet — point elsewhere, and are listed under Red Flags.

The reason is mechanical. One sensory nerve cell in your lower back must maintain a metre of axon reaching your big toe, supplied from a cell body the size of a speck of dust. That is expensive to run, so when anything degrades the cell's energy supply, transport machinery, or blood supply, the far end is abandoned first — length-dependent, or dying-back, degeneration. So it begins in both feet at once, in the toes, equally on each side; it ascends slowly over months to years, often with a clear border at a sock line; and the hands join later, once the legs are affected to roughly the knee, because arm nerves are shorter.

Back to Table of Contents

The Common Causes

Roughly half of all polyneuropathy is diabetic or prediabetic. Most of the rest comes from a short list: nutritional deficiency, alcohol, medications and chemotherapy, thyroid disease, kidney failure, and the genuinely idiopathic group.

Diabetic and Prediabetic Neuropathy

The largest single cause worldwide. High glucose damages nerves several ways at once — oxidative stress overwhelming the axon's mitochondria, advanced glycation end-products stiffening proteins, and injury to the tiny vasa nervorum capillaries that feed the nerve, which is therefore starved and poisoned at the same time.

It starts before the diagnosis. Impaired glucose tolerance alone is associated with small-fibre neuropathy, and many people labelled "idiopathic" turn out to have an abnormal 2-hour glucose tolerance test. And tight glucose control helps type 1 far more than type 2: intensive control substantially cut new neuropathy in type 1, while a Cochrane review in type 2 found only a small, not clearly significant reduction. Triglycerides, obesity, hypertension, and smoking carry independent weight in type 2, so the plan cannot be glucose alone. Screening should be annual, starting at diagnosis in type 2.

Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Several chemotherapy classes are directly neurotoxic, and this is a leading reason treatment gets dose-reduced or stopped. In a large meta-analysis, about 68% of patients had neuropathy within the first month and around 30% still had it at six months.

• Platinum drugs (cisplatin, oxaliplatin) accumulate in the dorsal root ganglia, which sit outside the blood–nerve barrier and are unprotected. Oxaliplatin also causes an acute cold-triggered dysesthesia — a cold drink brings immediate electric throat tightening and hand cramping — and platinum neuropathy is notorious for coasting, worsening for weeks to months after the last dose.
• Taxanes (paclitaxel, docetaxel) disrupt the microtubule railway carrying supplies down the axon; vincristine can abolish ankle reflexes early; bortezomib and thalidomide cause a painful small-fibre neuropathy, often dose-limiting in myeloma.

Report new numbness, burning, or buttoning difficulty at the visit it starts, not at the end of the cycle. Early dose modification is the only intervention with strong evidence for preventing permanent damage — the 2020 ASCO guideline update found no agent that reliably prevents CIPN, which makes early reporting the whole strategy.

Vitamin B12 Deficiency

B12 builds and maintains myelin, and its deficiency causes a neuropathy that is often fully reversible if caught early and permanent if not — the most important treatable cause to look for. Advanced deficiency also involves the spinal cord (subacute combined degeneration), adding severe balance loss and brisk rather than absent reflexes.

The risk list is longer than most people expect: metformin, whose long-term use lowers B12 in the very patients already at risk of diabetic neuropathy, so the two get conflated; years of acid suppression; pernicious anaemia; gastric bypass and celiac disease; unsupplemented vegan diets; and nitrous oxide, which inactivates B12 directly and can cause a devastating neuropathy in weeks. Critically, a "normal" serum B12 does not rule this out — damage occurs in the 200–350 pg/mL grey zone, so if the level is borderline and the picture fits, ask for methylmalonic acid and homocysteine, which rise before B12 falls. See Vitamin B12.

Alcohol-Related Neuropathy

Heavy drinking damages nerves twice over: ethanol and acetaldehyde are directly toxic to axons, and heavy drinkers are frequently short of thiamine (vitamin B1) and folate because alcohol displaces food and impairs absorption. The result is a painful, burning, small-fibre-predominant neuropathy of the feet. Abstinence plus repletion — thiamine first, before any glucose-containing IV fluid, to avoid precipitating Wernicke encephalopathy — halts progression, and partial recovery over months is common. See Alcohol Use Disorder and Vitamin B1.

Other Metabolic and Drug Causes

Hypothyroidism causes a generalised neuropathy and predisposes to compression neuropathies such as carpal tunnel syndrome, so a TSH belongs in every workup, and chronic kidney disease produces a uraemic neuropathy that improves with adequate dialysis. Vitamin B6 cuts both ways: deficiency causes neuropathy, but chronic pyridoxine above roughly 50–100 mg daily causes a severe sensory neuronopathy, which happens to people taking well-meant high-dose B-complex supplements (see Vitamin B6). Copper deficiency mimics B12 deficiency after bariatric surgery. Review prolonged metronidazole, nitrofurantoin, isoniazid, and amiodarone, and test for environmental toxins only with a real exposure history.

Idiopathic (Cryptogenic) Sensory Polyneuropathy

After a thorough workup, a quarter to a third of cases have no identified cause. This group is the one most often dismissed, and the dismissal is not warranted: it is a real diagnosis with a known behaviour — onset usually after 55, sensory-predominant, very slowly progressive, rarely causing significant weakness, not shortening life. Revisit it periodically, because some cases later prove to have impaired glucose tolerance or a monoclonal protein.

Back to Table of Contents

Serious and Less Common Causes

Individually uncommon, but not to be missed: most are treatable and several are time-critical.

Guillain-Barré Syndrome and CIDP

Guillain-Barré syndrome is an acute autoimmune attack on nerve myelin, often two to four weeks after a diarrhoeal or respiratory infection. It presents as rapidly ascending weakness and numbness over hours to days with lost reflexes, and can progress to paralysis of the breathing muscles. It is an emergency — immunoglobulin or plasma exchange works, and works better early. CIDP is its chronic cousin, evolving over more than eight weeks with weakness in the proximal muscles as well as the distal ones, absent reflexes, and little pain. Immunotherapy can restore function, yet it is regularly misdiagnosed for years as "just diabetic neuropathy." Weakness out of proportion to numbness is the tell.

Vasculitis, Monoclonal Proteins, and Amyloid

Inflammation of the small arteries feeding nerves makes individual nerves infarct one at a time, producing mononeuritis multiplex — a stepwise, asymmetric, painful pattern, such as a wrist drop this week and a foot drop next month. It occurs in systemic vasculitis and Sjögren's syndrome, and needs urgent immunosuppression. Separately, an abnormal antibody protein from a clone of plasma cells turns up in roughly one in ten otherwise unexplained neuropathies, which is why protein electrophoresis and free light chains belong in the workup. AL amyloidosis is the one to catch: painful small-fibre neuropathy plus autonomic failure plus weight loss, bilateral carpal tunnel, or heart failure should trigger urgent haematology referral.

Infections and Inherited Disease

HIV, Lyme disease, leprosy (still the leading infectious cause worldwide), and shingles with its postherpetic neuralgia all belong on the list. Charcot-Marie-Tooth disease is the commonest inherited neuropathy, around 1 in 2,500; the clues are onset in childhood or the teens, very high arches or hammer toes, and little pain for the amount of deformity.

Back to Table of Contents

Red Flags — Get Help Urgently

Most neuropathy develops over years and is worked up in clinic. The features below change that: they mean the process is fast, asymmetric, or compressing something, and the window for preventing permanent damage is measured in hours to days.

Go to an Emergency Department Now

• Weakness or numbness climbing your legs over hours to days, especially with lost reflexes — possible Guillain-Barré syndrome. Do not wait for a routine appointment.
• Difficulty breathing, a weak cough, or trouble swallowing with new weakness — the breathing and swallowing muscles may be failing.
• Numbness in the saddle area (inner thighs, genitals, buttocks) with new loss of bladder or bowel control, plus back pain — this is cauda equina syndrome, a surgical emergency, not a neuropathy.
• A band of numbness around the chest or abdomen, or a clear horizontal cut-off on the trunk — that level points to the spinal cord.
• Sudden foot drop or wrist drop, particularly with fever, rash, or joint pain — possible vasculitic nerve infarction.
• A hot, red, swollen or deformed foot in someone with diabetes — possible Charcot foot or deep infection. A numb foot can be badly infected and barely hurt.
• Severe new numbness after nitrous oxide use — acute B12 inactivation moves that fast.

Get an Appointment Within Days, Not Months

• Marked asymmetry — one foot or hand clearly worse, named nerves failing in sequence, symptoms starting in the hands, or rapid progression that is noticeably worse this month than last.
• Weakness out of proportion to numbness, or weakness in thighs and shoulders rather than only feet — think CIDP, which is treatable.
• Unexplained weight loss, night sweats, or fever alongside the neuropathy — see Unexplained Weight Loss and Night Sweats.
• Fainting on standing, inability to sweat, severe constipation or diarrhoea, or early fullness after eating — autonomic involvement narrows the differential considerably. See Lightheadedness on Standing.
• Any new foot ulcer, blister, dark callus, or wound that is not healing. In a numb foot this is urgent regardless of how it looks or feels.

Back to Table of Contents

How It Is Evaluated

A good workup answers three questions in order: Is this really neuropathy? What pattern is it? What is causing it? Skipping to the third is how people end up with expensive scans and no answer.

The Bedside Examination

Most of the diagnosis is made here, with a few dollars of equipment: the 10-gram monofilament pressed on the sole until it buckles, where failure to feel it marks a foot at risk of ulceration; a 128 Hz tuning fork on the big toe joint, since vibration loss is often the earliest large-fibre finding; pinprick and cold mapped upward to find the top of the "stocking"; ankle reflexes, where absent ankle jerks with intact knee jerks is the signature of a length-dependent process; the Romberg test, in which swaying with eyes closed means proprioception rather than the inner ear is failing; and foot inspection of skin, nails, calluses, and pulses.

Blood Tests

• Fasting glucose and HbA1c, and if both are normal a 2-hour oral glucose tolerance test, which catches impaired glucose tolerance that HbA1c misses.
• Vitamin B12, with methylmalonic acid and homocysteine if borderline.
• Serum protein electrophoresis with immunofixation and free light chains — the test most often left out, and the one that finds amyloidosis.
• TSH, a blood count, a metabolic panel, and ESR or CRP.

Nerve Testing

Nerve conduction studies and EMG confirm neuropathy, separate axonal from demyelinating damage (a critical fork — demyelinating patterns raise treatable CIDP or a hereditary neuropathy), and show whether motor fibres are involved. One caveat matters enormously: they assess only large fibres, so a normal EMG does not rule out small-fibre neuropathy, and many patients are wrongly told their symptoms are not real on the strength of a normal study. Skin punch biopsy for intraepidermal nerve fibre density is the reference test for small fibres; spine MRI and lumbar puncture are added when the pattern suggests cord disease, GBS, or CIDP.

What the doctor is ruling out, in plain terms: an inflammatory neuropathy needing immunotherapy this week, a treatable deficiency that becomes permanent if missed, a plasma-cell disorder or cancer signalling itself through the nerves, a cauda equina problem masquerading as neuropathy, and a drug or supplement quietly causing all of it that could simply be stopped.

Back to Table of Contents

What Helps: Self-Care and Physical Measures

Two goals run in parallel: stop the damage progressing, and make daily life liveable. Treating the cause means glucose control, B12 or thiamine repletion, stopping alcohol or the offending drug, thyroid replacement, adequate dialysis, or immunotherapy for CIDP. In type 2 diabetes especially, do not stop at glucose: triglycerides, blood pressure, weight, and smoking are independently linked to progression, and addressing them is part of the nerve treatment.

Exercise — The Most Underrated Intervention

This is the one patients dismiss and should not. Supervised aerobic plus resistance exercise reduces neuropathic symptoms and pain, and a 10-week supervised programme in diabetic peripheral neuropathy produced measurable increases in cutaneous nerve fibre branching on skin biopsy — structural regeneration, not just symptom relief. Practically: 30 minutes of moderate activity most days, strength work twice weekly, and deliberate balance training such as tandem stance or tai chi.

Foot Protection — Non-Negotiable

A numb foot cannot report injury, and roughly 15% of people with diabetes develop a foot ulcer, almost always with neuropathy as the precursor. This routine prevents amputations:

• Inspect both feet every day, soles and between the toes included — use a mirror on the floor or your phone camera.
• Never go barefoot, indoors or out, and shake out your shoes every time. Pebbles, tacks, and coins cause a startling number of ulcers.
• Test bathwater with an elbow or thermometer, not your foot, and never use a heating pad on numb feet.
• Wear well-fitted shoes with a wide, deep toe box, get custom insoles if you have deformity or a previous ulcer, and let a podiatrist handle calluses.

Falls, Night Pain, and Therapy

Neuropathy roughly doubles fall risk, mostly through lost position sense. Remove throw rugs, add night-lights on the route to the bathroom, install shower grab bars, and use a cane or walking poles on uneven ground — a pole restores some of the ground information your feet have stopped sending. Pain reliably worsens at night, so keep feet cool — a fan or a bed cradle holding the sheets off the toes helps many people. See Insomnia if sleep loss has become its own problem, and treat physiotherapy as a referral worth making, for gait retraining, balance work, and an ankle-foot orthosis if you have foot drop.

Supplements: Reasonable and Not

Replace documented deficiencies — B12, thiamine, folate, copper — at proper therapeutic doses; this is the only supplement intervention with strong evidence. Alpha-lipoic acid at 600 mg daily has the best data among the optional supplements, with modest symptom improvement in trials such as SYDNEY 2. And do not take high-dose vitamin B6 — above roughly 50–100 mg daily long term it can cause neuropathy. Check every label, including "nerve support" formulas, which often pair a hazardous dose of B6 with a sensible dose of B12.

When Medication Is Warranted

Medication is for pain and sleep disruption. No current drug reverses nerve damage or restores numb sensation, which is worth being clear-eyed about, because a treatment aimed at the wrong target will always feel like a failure. If pain interferes with sleep, walking, work, or mood, medication is appropriate and should be offered. For the best-supported agents, the number needed to treat for a 50% reduction in neuropathic pain is roughly 5 to 8: most people get partial relief, a minority get substantial relief, some get none. A 30–50% reduction with better sleep is a genuine success; expecting zero pain sets up an endless drug rotation.

• Duloxetine (an SNRI), 30 mg daily for a week then 60 mg. Strong evidence in diabetic neuropathy, and notably the one agent with positive randomised-trial evidence in chemotherapy-induced neuropathic pain. Also treats coexisting depression; first-week nausea usually settles.
• Gabapentin, titrated over weeks toward 1,800–3,600 mg daily in divided doses. Cheap and widely used, but frequently prescribed at ineffective doses and then written off — 300 mg at night is a starting dose, not a treatment dose. Sedation and ankle swelling are the usual limits.
• Tricyclics — amitriptyline, or better tolerated in older adults nortriptyline, 10–25 mg at bedtime titrating toward 75 mg. Effective, inexpensive, and usefully sedating at night, but anticholinergic effects and cardiac conduction risk limit use over about 65.
• Topicals are underused: 5% lidocaine patches have almost no systemic absorption and suit frail or heavily medicated people, and the capsaicin 8% patch is a single clinic-applied treatment lasting up to three months.

Opioids fit essentially nowhere in chronic neuropathic pain: reviews show at best modest short-term benefit, no long-term function gain, and substantial harms — tolerance, dependence, hyperalgesia, falls. If you are already on long-term opioids, this is a conversation about slow, supported tapering with a better regimen in place, not an abrupt stop. Pain-focused cognitive behavioural therapy meaningfully improves function and distress, and spinal cord stimulation has randomised evidence in refractory painful diabetic neuropathy. See Neuropathic Pain.

Back to Table of Contents

What to Expect Over Time

A damaged axon with an intact cell body can regrow, but at roughly 1 millimetre per day — about an inch a month, so regrowing from ankle to toes takes months and from the knee down closer to a year. Demyelinating injury, where the insulation rather than the wire is damaged, recovers much faster once the cause is removed; if the nerve cell body itself has died, that fibre does not come back. The practical consequence: improvement is invisible week to week. Judge progress across three-to-six-month intervals and keep a monthly log of pain score, walking distance, and stumbles.

• B12, thiamine, and copper deficiency — often substantial or complete recovery if treated within months, partial at a year, and frequently permanent after prolonged deficiency, especially where the spinal cord was involved.
• Drug-, toxin-, and chemotherapy-induced — usually stabilises and improves after withdrawal, with most recovery in the first six to twelve months, though platinum drugs coast for a few weeks first and fine fingertip sensation recovers less completely than pain does.
• Diabetic — slowly progressive, but the rate is modifiable. Sensation already lost is rarely regained; further loss usually can be prevented. Pain may subside as numbness deepens, which is not improvement.
• Idiopathic sensory polyneuropathy — the most reassuring natural history: very slow progression, weakness uncommon, disability driven by pain and balance rather than paralysis, no effect on life expectancy.

Two closing points. Chronic neuropathic pain carries a high rate of coexisting depression and anxiety, and treating those improves pain scores too. And if you were told "it's just neuropathy, nothing can be done," get a second opinion, ideally from a neuromuscular specialist — the list of treatable causes above is long, the workup that finds most of them is a single blood draw, and a normal nerve conduction study does not mean your small fibres are healthy.

Back to Table of Contents

Connections

• All Symptoms
• Numbness and Tingling
• Cold Hands and Feet
• Peripheral Neuropathy (Neurology)
• Neuropathic Pain
• Guillain-Barré Syndrome
• CIDP
• Diabetes
• AL Amyloidosis
• Vitamin B12
• Vitamin B1 (Thiamine)
• Alpha-Lipoic Acid

References & Research

Key Research Papers

1. Pop-Busui R, Boulton AJM, Feldman EL, et al. Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care. 2017;40(1):136-154 — Search PubMed.
2. Seretny M, Currie GL, Sena ES, et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain. 2014;155(12):2461-2470 — Search PubMed.
3. Smith EML, Pang H, Cirrincione C, et al. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA. 2013;309(13):1359-1367 — Search PubMed.
4. Loprinzi CL, Lacchetti C, Bleeker J, et al. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update. J Clin Oncol. 2020;38(28):3325-3348 — Search PubMed.
5. Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162-173 — Search PubMed.
6. Callaghan BC, Little AA, Feldman EL, Hughes RAC. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database of Systematic Reviews. 2012;(6):CD007543 — Search PubMed.
7. Ziegler D, Ametov A, Barinov A, et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care. 2006;29(11):2365-2370 — Search PubMed.
8. Kluding PM, Pasnoor M, Singh R, et al. The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy. J Diabetes Complications. 2012;26(5):424-429 — Search PubMed.

Back to Table of Contents

Featured Videos